A retrospective study of treosulfan versus busulfan-based conditioning in pediatric patients.

Olivas-Mazón, Raquel; Bueno, David; Sisinni, Luisa; Mozo, Yasmina; Casado-Abad, Gema; Martínez, Antonio Pérez

Olivas-Mazón, Raquel; Bueno, David; Sisinni, Luisa; Mozo, Yasmina; Casado-Abad, Gema; Martínez, Antonio Pérez.

Affiliation

Olivas-Mazón R; Pediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain.
Bueno D; Pediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain.
Sisinni L; Pediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain.
Mozo Y; Pediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain.
Casado-Abad G; Pharmacy Department, La Paz University Hospital, Madrid, Spain.
Martínez AP; Pediatric Hemato-Oncology Department, La Paz University Hospital, Madrid, Spain.

Eur J Haematol ; 109(5): 474-482, 2022 Nov.

Article in En | MEDLINE | ID: mdl-35810360

Subject(s)

Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Busulfan/adverse effects; Busulfan/analogs & derivatives; Child; Graft vs Host Disease/epidemiology; Graft vs Host Disease/etiology; Graft vs Host Disease/prevention & control; Hematopoietic Stem Cell Transplantation/adverse effects; Humans; Retrospective Studies; Transplantation Conditioning/adverse effects

Key words

HSCT-conditioning; busulfan; pediatric; treosulfan

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cell Transplantation / Graft vs Host Disease Type of study: Etiology_studies / Observational_studies Limits: Child / Humans Language: En Journal: Eur J Haematol Journal subject: HEMATOLOGIA Year: 2022 Type: Article Affiliation country: Spain

Fulltext

XML

PubMed Links

Search on Google